Discover Nano
·
2026
·Vol. 21
·期 1
·415
·
IF 6.7
Long Lin,Zhang Yexi,Xiao Jun,Zang Jianhua
Purpose To fabricate hesperetin-loaded fucoidan-selenium (Hes/Fu-Se) nanoparticles (NPs) for alleviating cisplatin-induced acute kidney injury (AKI), overcoming hesperetin’s low solubility and bioavailability and boosting antioxidant and anti-inflammatory efficacy. Methods Hes/Fu-Se NPs were prepared by encapsulating hesperetin within fucoidan, and then functionalized selenium (Se) NPs. Nanoparticle physicochemical properties and antioxidant activity (FRAP, ABTS) were characterized. Cisplatin-stimulated HK-2 cells were used for in vitro detection of cell viability, apoptosis, ROS accumulation, mitochondrial function and cGAS-STING signaling. A cisplatin-induced AKI mouse model was adopted to test renal biochemical indexes, renal histopathology and renal injury-related protein expression. Results Synthesized Hes/Fu-Se NPs exhibited uniform particle size, superior aqueous solubility and potent antioxidant activity. In vitro, the NPs restored HK-2 cell viability, mitigated apoptosis and ROS overproduction, and inhibited DNA damage and cGAS-STING cascade activation. In vivo, Hes/Fu-Se markedly reduced serum BUN and CRE, alleviated renal histological lesions and inflammatory infiltration, and downregulated the expression of cGAS, STING, γH2AX and TNF-α in kidney tissues. Conclusions Hes/Fu-Se NPs relieve cisplatin-triggered AKI via amplified antioxidation, DNA damage restoration and cGAS-STING pathway suppression. This nanoformulation provides a promising nephroprotective strategy against chemotherapy-related renal toxicity for clinical translation. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF NANOBIOTECHNOLOGY
·
2026
·
IF 15
Deng Shuang,Zhao Chaoqian,Meng Huanliang,Han Jianmei,Du Jianhang,Ghorbani Farnaz,Guan Zhengmao,Yi Chengqing,Li Dejian
The repair of osteoporotic bone defects remains challenging because of the hostile pathological microenvironment—resembling “barren soil”—characterized by excessive oxidative stress and persistent inflammation, which impair cell survival and tissue regeneration. To address this problem, we developed a “fertile soil” implant system as a ready-to-use platform for osteoporotic bone regeneration. It consists of: (1) a three-dimensional (3D) -printed β-tricalcium phosphate/gelatin methacryloyl (β-TCP/GelMA) composite scaffold as a structural “soil matrix,” and (2) a Kaempferol-loaded ZIF-8 metal organic framework as an “intelligent nutrient bank” that responsively releases zinc ions and Kaempferol in acidic osteoporotic conditions.In vitro, the implant promoted a shift in macrophage polarisation from a pro-inflammatory M1 phenotype towards a pro-regenerative M2 phenotype. Mechanistic studies showed that this immunomodulatory effect was associated with improved mitochondrial function and reduced mitochondrial DNA (mtDNA) accumulation, accompanied by suppression of the cGAS–STING–TBK1–NF-κB signaling pathway. The implant reversed inflammation-induced metabolic reprogramming in macrophages by reducing glycolytic activity and restoring oxidative phosphorylation, thereby favouring the re-establishment of immune homeostasis. In parallel, the implant directly enhanced the osteogenic differentiation of mesenchymal stem cells and inhibited osteoclastogenesis, helping to restore the balance of bone remodelling. Conditioned-medium experiments further demonstrated that scaffold-mediated macrophage reprogramming established a pro-regenerative microenvironment that indirectly promoted osteogenesis and restrained osteoclast formation. In osteoporotic bone defect models, implantation enhanced new bone formation, improved trabecular microarchitecture, tissue integration, and vascularisation, and reduced local inflammation.In summary, this “ready-to-move in” osteoporotic bone repair system remodels the hostile microenvironment through immunomodulation and direct cell regulation, providing a “fertile soil” that may enhance bone defect repair under osteoporotic conditions. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
Nature Catalysis
·
2026
·
IF 48.3
Ding Liang,Yao Ze-Cheng,Tang Tang,Wan Xin,Liu Xiaozhi,Jiang Zhe,Fu Jiaju,Shi Zhuo-Qi,Tai Jing,Lyu Zhen-Hua,Dong Jichen,Li Qing,Su Dong,Shui Jianglan,Hu Jin-Song,Wan Li-Jun
High-performance cathode catalysts are essential for proton-exchange membrane fuel cells. Intermetallic nanocrystals are promising candidates but suffer from intrinsic activity–durability trade-offs because their comprehensive catalytic properties are determined by several intertwined structural factors that cannot be optimized independently by existing synthesis techniques. The challenge lies in the inherent thermodynamic and kinetic constraints during synthesis. Here we develop a decoupled synthesis strategy that leverages block-copolymer micelle confinement, which enables the customized synthesis of libraries of intermetallic nanocrystals, simultaneously achieving ultra-small size, ultra-high ordering degree, tailorable loading density, narrow size distribution, compositional uniformity, and broad compositional and substrate universality. The developed Pt 3 Co intermetallic nanocrystal/Ketjenblack catalyst achieves a rated power density of 1.08 W cm −2 and 92% rated power retention after 30,000 cycles under light-duty-vehicle conditions and 900 h of stable operation at 10 A. It also delivered a 70.2% cell efficiency without degradation and 98.4% specific power retention after 90,000 cycles of heavy-duty-vehicle applications. This performance led us to project a lifetime of 240,000 h.
✓ 已验证
产品关联
DOI
高影响因子
Cell Death Discovery
·
2026
·
IF 10.4
Zhen Shuman,Bai Xiaoxue,Liu Shutang,Zhang Haoran,Ren Xuejiao,Li Xiaoning,Dong Hua,Li Xiaoxu,Han Chun,Wang Lan
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly improved outcomes in EGFR-mutant lung adenocarcinoma (LUAD), yet acquired resistance to the third-generation inhibitor osimertinib remains inevitable. Although metabolic reprogramming is increasingly recognized as a driver of therapeutic resistance, the epigenetic consequences of lactate accumulation and their functional relevance in osimertinib resistance are poorly understood. Here we report that osimertinib-resistant LUAD cells exhibit enhanced glycolytic flux, increased intracellular lactate levels, and elevated histone H4 lysine 8 lactylation (H4K8la). Integrative transcriptomic analysis revealed significant enrichment of cell-cycle–associated pathways in resistant tumors, despite downregulation of canonical Cyclin B1 and Cyclin D1. Among the upregulated genes, GAS2L3 emerged as a prominent candidate. Genome-wide CUT&Tag profiling demonstrated enrichment of H4K8la at the GAS2L3 promoter, which was confirmed by ChIP–qPCR. Functionally, GAS2L3 overexpression accelerated S/G2–M progression and promoted proliferation under drug pressure, whereas its silencing induced cell-cycle arrest and restored osimertinib sensitivity both in vitro and in xenograft models. Notably, resistant cells displayed elevated P53 expression without induction of its canonical effector P21, indicating checkpoint uncoupling and a noncanonical mode of cell-cycle regulation. Mechanistically, glycolysis inhibition reduced H4K8la and GAS2L3 expression and partially re-sensitized resistant cells, while exogenous lactate restored H4K8la levels and resistance phenotypes, establishing a metabolically driven epigenetic circuit. Clinically, high GAS2L3 expression was associated with shorter progression-free survival in osimertinib-treated patients. Collectively, our findings identify a glycolysis–H4K8la–GAS2L3 axis that drives noncanonical cell-cycle reprogramming independently of classical Cyclin–CDK activation, thereby promoting acquired osimertinib resistance. These results uncover a metabolism-epigenetics–cell cycle interface that may represent a therapeutic vulnerability in EGFR-mutant LUAD.
✓ 已验证
产品关联
DOI
高影响因子
Microorganisms
·
2026
·Vol. 14
·期 8
·1814
·
IF 4.7
Huipeng Liu,Xining Geng,Yousi Fu
Pectin oligosaccharides have emerged as promising prebiotics whose biological activities are closely tied to their structural features, particularly monosaccharide composition. However, systematic experimental evidence regarding how different monosaccharide compositions collectively influence gut microbiota modulation, SCFA production, and the metabolomic responses of mixed pectin oligosaccharides remains limited. To address this gap, Pool-I (27.92% galacturonic acid, rich in neutral sugars including galactose, glucose, and arabinose) and Pool-II (98.73% galacturonic acid) were evaluated by comparison with inulin, a reference prebiotic, using an in vitro human fecal fermentation model. Microbial community structure, SCFA production, and metabolomic profiles were assessed at 12 h and 24 h via 16S rRNA gene sequencing, gas chromatography, and untargeted metabolomics, respectively. Inulin exhibited superior enrichment of Actinobacteria (predominantly Bifidobacterium ) and consistently higher total SCFA production (24.07 ± 0.25 mmol/L acetic acid at 24 h vs. 20.27 ± 0.28 and 20.53 ± 0.76 mmol/L for pectin oligosaccharides), particularly propionic and butyric acids. Although Pool-I and Pool-II yielded lower overall SCFA concentrations, they significantly enriched beneficial SCFA-producing genera (including Coprococcus_3 , Butyricicoccus , and Parabacteroides ) at 24 h. Metabolomic analysis revealed that Pool-I uniquely upregulated twenty-six differential metabolites ( VIP > 1, p < 0.05), including taurine ( VIP = 2.40, p < 0.001), L-proline ( VIP = 1.72, p = 0.015), and pantothenate ( VIP = 1.63, p < 0.001), while reducing uric acid ( VIP = 1.05, p < 0.001), whereas only two differential metabolites were identified for Pool-II. We conclude that monosaccharide composition is a key determinant of the prebiotic efficacy of pectin oligosaccharides: Pool-II selectively promotes SCFA-producing taxa, whereas Pool-I elicits broader metabolic regulation. These effects provide a theoretical foundation for developing pectin oligosaccharides as potential prebiotic candidates.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Cell Death & Disease
·
2026
·
IF 12.2
Liu Yanyan,Guan Chenxi,Xu Linlin,Yang Jianhua,Wang Jinglei,Yang Si,Chen Jiaxiang
Impaired Leydig cell function leads to low testosterone levels, which is associated with male reproductive developmental defects and functional disorders. Exposure to di(2-ethylhexyl) phthalate (DEHP), an endocrine-disrupting chemical, can cause damage to Leydig cells, yet the underlying mechanism remains unclear. In this study, we found that DEHP exposure decreased serum testosterone levels and triggered ferroptosis of mouse Leydig cells by inhibiting GPX4 expression. Subsequently, mono(2-ethylhexyl) phthalate (MEHP), the primary active metabolite of DEHP, was shown to suppress the transcription of Gpx4 gene in TM3 cells by downregulation of HOXA3, which bound to the −264 to −258 region (RE3) of Gpx4 gene promoter. Concurrently, MEHP promoted HSC70 to recognize and degradate GPX4 protein via chaperone-mediated autophagy (CMA). Furthermore, both overexpression of HOXA3 and inhibition of CMA significantly abrogated MEHP-induced ferroptosis of TM3 cells through upregulating the expression of GPX4. Ultimately, tannic acid (TA), a natural polyphenol, was identified to increase the expression of GPX4 and inhibit MEHP-induced ferroptosis of TM3 cells, thereby alleviating DEHP-caused testicular damage in mice through the upregulation of HOXA3 and inhibition of CMA.
✓ 已验证
产品关联
DOI
高影响因子
Frontiers in Immunology
·
2026
·
IF 7
Yi-Chen Lv,Jie-Hao Zhou,Tie-Feng Shi,Yun-Fu Cui
ObjectiveThis study aimed to characterize molecular subtypes of Papillary thyroid carcinoma (PTC) and identify novel therapeutic targets and potential therapeutic compounds.MethodsWe performed integrative analysis of TCGA data, including consensus clustering, mutational profiling, copy number variation (CNV) analysis, functional enrichment (GO and GSEA), and immune microenvironment assessment (CIBERSORT). Validation utilized GEO datasets. The biological function of Plectin (PLEC) was investigated through expression analysis (TCGA, GEO, qRT-PCR and IHC), association with clinical parameters, and functional experiments such as siRNA knockdown or overexpression of PLEC in TPC-1 and B-CPAP cell lines assessing cell growth, proliferation, apoptosis, and migration both in vitro and in vivo. Drug candidates targeting PLEC were screened (DGIdb and DrugMap) and validated via molecular docking, dynamics simulations (RMSD, RMSF and Rg), and rescue experiments. Favorable biosafety was tested by ELISA kits and H&E staining.ResultsConsensus clustering revealed four stable molecular subtypes (A1-A4) with distinct mutational landscapes (e.g., prevalent BRAF mutations (59%), subtype-specific alterations in CAND1/PCDH11X (A1) and PTEN (A4)), CNV gains (e.g., A1: 2p16.1/19p13.3), and immune features (A3 enriched in immune pathways). PLEC is up-regulated in PTC tissues compared with non-tumor thyroid tissues and was associated with lymph node metastasis, histological type, and residual tumor status in TCGA-THCA. Knockdown of PLEC significantly suppressed PTC cell growth, proliferation, and migration while inducing apoptosis. Whereas PLEC overexpression partially reversed these phenotypes. Among FDA-approved drugs predicted to target PLEC, Troglitazone exhibited the lowest binding affinity (-7.5 kcal/mol). Troglitazone’s anti-tumor effects (inhibiting proliferation/migration, inducing apoptosis) were partially reversed by PLEC overexpression, suggesting that PLEC may participate in Troglitazone-associated anti-PTC effects.ConclusionThese findings identify PLEC as a candidate molecule associated with aggressive PTC phenotypes and provide preliminary evidence supporting its biological relevance, although larger independent cohorts are required to validate its clinical significance.
✓ 已验证
DOI
高影响因子
Nature Communications
·
2026
·
IF 18.1
Yang Zixuan,Zhang Yu,Huang Zhen,Chu Liangyong,Zhang Lingjie,Bao Ningzhong
High‑strength, tough hydrogels are urgently needed for biomedicine and soft robotics, yet single‑network architectures suffer from an inherent trade‑off between mechanical robustness and high water content. Herein, we propose a rectangular topological network (RN) composed of rectangular motifs in a single-network hydrogel via stoichiometric crosslinking of long and short polymer chains. This architecture achieves a high elastic modulus via dense intermolecular hydrogen bonds while maintaining large mesh sizes. Driven by a strain-induced hardening mechanism, the hydrogel achieves a simultaneous increase in strength and toughness. Successful fabrication using two crosslinkers demonstrates broad applicability. A representative PEG‑based RN hydrogel exhibits a Young’s modulus of 21.97 MPa, a toughness of 31.04 MJ·m −3 , and a tensile strength of 7.72 MPa. Thus, we show that this facile and versatile RN strategy offers a route for high‑energy dissipation and can be extended to other platforms.
✓ 已验证
产品关联
DOI
高影响因子
AESTHETIC PLASTIC SURGERY
·
2026
·
IF 2.7
Li Tian-Xi,Lang Ming-Fei,Su Di-Ya,Zhang Chen,Wang Shi-Hui,Dong Xiao-Ying,Han Cheng,Wang Jie-Qing,Sun Jing
Objective Despite its good biocompatibility and processability, the severe surface hydrophobicity of polydimethylsiloxane (PDMS) limits its biomedical applications. This study aimed to enhance the surface properties of PDMS by depositing gelatin onto it via polydopamine (PDA) mediation and to evaluate the resulting cell–material interactions. Methods and Results The 1% gelatin-modified PDA-PDMS (G-PDA-PDMS) group showed the highest cell viability at 48 h. Surface hydrophilicity was significantly improved, with the contact angle reduced to 21.97° ± 2.06 ( p <0.01). XPS confirmed successful modification, showing increased nitrogen signal and characteristic C=O/C-N peaks on G-PDA-PDMS. AFM revealed significantly higher surface roughness and altered nano-topography compared to PDMS ( p <0.05). After interacting with cells, it was observed that the cell viability of G-PDA-PDMS was significantly higher than that of the other two groups ( p <0.05). FITC/DAPI fluorescence staining showed that the number of cells in G-PDA-PDMS was higher than that in PDMS ( p <0.05), and it exhibited a better cell spreading area ( p <0.05). Calcein AM/PI fluorescence staining showed that the proportion of red fluorescence in PDA-PDMS and G-PDA-PDMS decreased significantly, while the green fluorescence increased significantly, indicating that they had a better cell survival rate compared with PDMS ( p <0.05). The cell scratch test showed that the cell migration rate of G-PDA-PDMS was higher than that of PDA-PDMS ( p <0.05). At the molecular level, G-PDA-PDMS significantly upregulated the mRNA expression of TGF-β1 , COL3A1 , COL1A1 , and α-SMA ( p <0.05), which was corroborated by increased TGF-β1 protein production ( p <0.05). Conclusion Gelatin was successfully modified onto PDA-PDMS. The resulting G-PDA-PDMS material significantly improves surface hydrophilicity, enhances fibroblast proliferation and adhesion, and upregulates key extracellular matrix-related gene and protein expression, demonstrating excellent bioactivity and potential for biomedical applications. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable
✓ 已验证
产品关联
DOI
高影响因子
Nature Communications
·
2026
·
IF 18.1
Xie Han,Chen Tucan,Yan Peiyu,Fu Yuqi,Lei Mengcheng,Liu Yuanyuan,Zhao Xudong,Du Wei,Feng Xiaojun,Liu Xin,Li Yiwei,Chen Peng,Liu Bi-Feng
Extracellular vesicles (EVs) are promising non-invasive biomarkers for early cancer detection, yet clinical translation is limited by membrane fouling during isolation and vesicle aggregation during single-vesicle imaging. Here, iEVIP (intelligent extracellular vesicle isolation and profiling), an integrated dual-inspired platform, combines intelligent pulsatile filtration, blood-smear-inspired nanoscale organization and machine-learning-based classification. Real-time transmembrane-pressure monitoring triggers back-aspiration pulses upon membrane fouling, promoting membrane regeneration and stable EV recovery from plasma. A wettability-assisted nano-smear array reduces aggregation and fluorescence overlap, enabling high-throughput multiplexed single-EV imaging. iEVIP achieves 95.32% classification accuracy for cell-line-derived EVs and up to 80.37% in exploratory clinical cohorts using random forest algorithm. By bridging macroscopic engineering principles with nanoscale bioanalysis, iEVIP provides a scalable framework for high-throughput single-EV analysis and exploratory clinical sample classification. However, the limited cohort size and absence of cross-center external validation constrain generalizability, and larger independent cohorts are needed to establish diagnostic robustness and clinical applicability.
✓ 已验证
产品关联
DOI
高影响因子
Frontiers in Sustainable Food Systems
·
2026
·
IF 4.1
Yaqian Yang,Ruiqi Liu,Yulei Qin,Jiashan Shen,Yangzhu Shi,Yizhe Cheng,Qiumin Lv
This study developed a green and sustainable extraction method for anthocyanins from Solanum betaceum peel using choline chloride–based natural deep eutectic solvents (NADES). Among seven tested systems, the choline chloride−1,4-butanediol (ChCl–BD) NADES exhibited the highest extraction yield (26.8 mg/g), significantly outperforming conventional 60% ethanol (12.3 mg/g). Optimization yielded ideal conditions of 60 °C, 1 h, a solid–liquid ratio of 1:20 g/mL, and 30% water content. The ChCl–BD DES showed good recyclability, retaining over 79% efficiency after four reuse cycles. Characterization by SEM, FTIR, and XRD confirmed effective disruption of the lignocellulosic matrix, facilitating anthocyanin release. Molecular docking revealed stronger interactions between anthocyanins and DES components than ethanol. The DES extract displayed superior thermal and storage stability, low cytotoxicity, and markedly better antioxidant, antibacterial, anti-inflammatory, and tyrosinase-inhibitory activities compared with the ethanol extract. Moreover, the DES extract exhibited enhanced skin permeation in a Franz diffusion cell assay, achieving 33.61% dermal absorption after 4 h. These results demonstrated that ChCl–BD NADES could serve as an efficient, recyclable, and multifunctional extraction platform, producing anthocyanin-rich extracts with promising applications in the fields of functional foods, cosmetics and pharmaceuticals.
✓ 已验证
DOI
高影响因子
MOLECULAR BIOLOGY REPORTS
·
2026
·Vol. 53
·期 1
·1444
·
IF 3.2
He Yalun,Ding Jie,Li Yangshuo,Sun Ji,Wei Cuiping,Sun Na,Jiang Runnan,Zhao Ziming,Liang Xiaolan,Chen Yiming,Cheng Wen,Zhang Litai,Song Di,Sun Shuai,Yu Chaoqin
Background Endometriosis (EMS) is an oestrogen-dependent chronic inflammatory disease that primarily manifests as chronic pelvic pain and infertility. EMS-associated infertility is closely linked to diminished ovarian function and oocyte quality, with the aberrant function of granulosa cells (GCs). Cellular senescence has a nonnegligible effect on female fertility. GCs in EMS patients may undergo senescence, subsequently compromising their nutritional support to oocytes and impairing ovarian function, ultimately contributing to infertility. Icaritin (Ica) possesses various biological activities including anti-tumour, anti-inflammatory, anti-oxidation and anti-aging. Methods Follicular fluid (FF) was collected from normal control females and EMS patients. GCs were extracted from FF for RNA sequencing and bioinformatic analysis. NADH: ubiquinone oxidoreductase core subunit S8 (NDUFS8)-knockdown KGN cells were established using shRNA-mediated lentiviral transduction. Pro-oxidants and oxidation scavengers were employed to modulate reactive oxygen species (ROS) levels. Network pharmacology was employed to analyse potential mechanisms of Ica in treating EMS. Ica was employed to intervene EMS-FF-treated KGN cells and EMS mice. Results Ica significantly reduced degrees of peritoneal adhesions, decreased quantities and volumes of ectopic lesions and improved reproductive capacity in EMS mice. Moreover, Ica may inhibit ovarian GC senescence and improve ovarian function in EMS mice by regulating NDUFS8/ROS/P53/P21 axis. In vitro experiments demonstrated that Ica may inhibit EMS-FF-induced KGN cell senescence by regulating NDUFS8/ROS/P53/P21 axis. Conclusions These findings identify Ica as a GC senescence-inhibiting agent with therapeutic potential in EMS-associated infertility.
✓ 已验证
DOI
高影响因子